|
|
See Category: Neoplasms
See Header: Malignant melanoma of trunk
ICD-10 (CM) Code and Descriptor
|
C43.59 |
Malignant melanoma of other part of trunk
|
C4359 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 58.14%
|
23.91%
|
7.62%
|
3.72%
|
2.01%
|
1.28%
|
0.85%
|
0.75%
|
0.45%
|
0.29%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C43.59*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
10,431
|
10,485
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
7,468
|
7,469
|
|
80053
|
COMPREHEN METABOLIC PANEL |
7,452
|
7,453
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
6,714
|
6,738
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
4,903
|
6,302
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
3,836
|
3,839
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
3,303
|
5,226
|
|
84443
|
ASSAY THYROID STIM HORMONE |
3,146
|
3,148
|
|
J3010
|
FENTANYL CITRATE INJECTION |
2,729
|
4,423
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
2,606
|
76,112
|
|
A9552
|
F18 FDG |
2,559
|
2,560
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
2,474
|
7,096
|
|
J2405
|
ONDANSETRON HCL INJECTION |
2,435
|
10,464
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
2,382
|
3,863
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
2,377
|
9,913
|
|
78816
|
PET IMAGE W/CT FULL BODY |
2,180
|
2,180
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
2,111
|
211,893
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
2,109
|
8,999
|
|
71260
|
CT THORAX DX C+ |
2,039
|
2,039
|
|
11606
|
EXC TR-EXT MAL+MARG >4 CM |
1,992
|
2,002
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C43.59 related to the following DRG Codes:
595-596
|
